By using this immune competent tumor model, we found that anti-HER2 CAR-T cells could likely infiltrate into tumors (Figures 8C,E), inhibit growth (Figure 7), change histomorphology (Figure 8A), and increase apoptosis (Figures 8B,D) of HER2+ tumors. This evidence concerns the gene ERBB2 and neoplasm.